U-M Health System hospitalist Vineet I. Chopra, M.D., M.Sc. has been awarded the Blue Cross Blue Shield Foundation of Michigan’s Frank J. McDevitt, DO Excellence in Research Award, which recognizes research that contributes to improving health and medical care in Michigan.
Chopra received the recognition for his study that was published in The Lancet last May showing that commonly used peripherally inserted central catheters increase risk of blood clots in ICU, cancer and hospitalized patients. Chopra will be awarded $10,000 in research funds to be used to conduct clinical and health policy research.
“We are honored by this recognition from the Blue Cross Blue Shield Foundation of Michigan,” says Chopra, an assistant professor of internal medicine at the U-M Medical School. “Peripherally inserted central catheters are often the go-to-device for doctors because they are safe, convenient and many times, the best choice for a patient. However, we are learning that their use also comes with risks and doctors should be carefully consider these when determining which patients should receive this device.”
“Our findings have had a significant impact on practice and policies regarding use of peripherally inserted central catheters. Clinicians across Michigan are becoming better informed about the precise risk and benefits related to these catheters – ultimately translating into better choices for our patients.”
Several hospitals, including the U-M Health System, have begun to evaluate and modify practices related to these devices, adopting more stringent policies for their use. A multihospital program focused on PICC use across 42 Michigan Hospitals has also been launched to prevent PICC complications, an initiative that was driven in part by the findings of this work.
The Society of General Internal Medicine and the American Board of Internal Medicine have also cited Chopra’s paper in their highly acclaimed “Choosing Wisely Campaign,” specifically recommending restraint when it comes to use of these devices in hospitalized patients. The research has also garnered important international recognition, including praise from the Center for Reviews and Dissemination (DARE) at the University of York, an independent reviewer that advises the National Institute for Health Research in the United Kingdom.